When and how COVID-19 vaccines become available around the world

Pfizer, Modern and AstraZeneca have already started manufacturing their vaccines. (Representative)

New York:

Pfizer Inc., along with its partners BioNotech SE and Modern Inc., released test data showing that their COVID-19 vaccines are about 95% effective in preventing disease, while AstraZeneca plc said its vaccine was up to 90% efficient. Can.

If regulators approve vaccines in the coming weeks, companies said it could start almost immediately with governments around the world deciding who and in what order they get them. Here’s an overview of the process:

When will companies vaccinate?

Pfizer, Modern and AstraZeneca have already started manufacturing their vaccines. This year, Pfizer said it would be enough to vaccinate 25 million people, Modern would have enough for 10 million people and AstraZeneca would have enough for more than 100 million people.

The US Department of Defense and the Centers for Disease Control and Prevention (CDC) will handle distribution in the United States, possibly starting in mid-December with a first release of 6.4 million doses.

British health officials plan to roll out an approved vaccine as soon as possible, which is also expected in December.

In the European Union, it is up to each member of the 27 countries to start distributing vaccines to their populations.

Who will receive an approved vaccine in the United States and when?

When cleared by the U.S. Food and Drug Administration, the CDC said approximately 21 million healthcare workers and 3 million residents will be the first in long-term care facilities in line. waiting for vaccination.

Essential workers, a group of 87 million people who perform important tasks in tasks that cannot be performed at home, are likely the next group. This includes firefighters, police, school workers, transportation workers, food and agriculture workers, and food service workers.

Nearly 100 million adults with high-risk health conditions and 53 million adults over 65 considered to be at high risk for serious illness are the next priority.

U.S. public health officials have said the vaccines will be available to most Americans, typically at drugstores, clinics, and doctors’ offices from April so anyone who wants to get the shot can get one. here the end of June.

It is not known when the vaccine will be available for children. Pfizer and BioNotech began testing their vaccines at the age of 12 in volunteers.

When will the vaccine be available in other countries?

The European Union, United Kingdom, Japan, Canada and Australia are increasingly implementing vaccine regulatory processes.

This year, several doses of AstraZeneca are expected to be sent to the UK, where health officials have said they could start vaccinating people in December if approved. At the top of their list are people living and working in nursing homes.

In Europe, the EU’s medicines regulator has said it could rule on the safety of a COVID-19 vaccine in December.

Most countries said the first vaccines would go to weak workers and frontier workers such as the elderly and doctors.

Countries say they buy the vaccines under a European Commission joint purchasing program, which deals with six different vaccines and around 2 billion doses.

Delivery times vary and most countries are still making plans to distribute and administer the injections.

Italy is expected to receive the first deliveries from Pfizer-BioNtech Schott and AstraZeneca Schott early next year. Spain plans to deliver the vaccine in January.

In Bulgaria, the country’s chief health inspector expects the first shipment in March-April. Hungary’s Foreign Minister said the dose would decrease in the spring as soon as possible.

Germany, the headquarters of BioNTech, hopes to launch shots in early 2021 with large vaccination centers in exhibition halls, airport terminals and concert halls. It will also use mobile teams for nursing homes. Frontline health workers and those at risk for severe COVID-19 should be vaccinated first.

When will vaccines reach developing countries?

$ 2 billion was raised by pooled funds in rich countries and associations led by COVAX, the World Health Organization and the GAVI Vaccine Group to purchase and distribute the vaccine to dozens of poor countries.

Its first objective is to immunize 3 percent of the inhabitants of these countries, with the ultimate goal of reaching 20%. He signed an interim agreement to purchase the AstraZeneca vaccine, which does not require storage in special ultra-cold equipment such as the Pfizer vaccine.

Less wealthy countries in India, such as Africa and Southeast Asia, are expected to receive little or no fees under this program in 2021. Other countries like Latin America can buy vaccines through COVAX. There are also supply agreements with several pharmaceutical manufacturers.

How much will it cost?

Vaccine manufacturers and governments have negotiated different prices, not all of which are public. Governments paid up to $ 50 for a few dollars per two-dose Pfizer injection of AstraZeneca. Many countries have said they will cover the cost of vaccinating their residents.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: